Read-Gene S.A. (WSE:RDG)
5.20
0.00 (0.00%)
Last updated: Aug 11, 2025
Read-Gene Revenue
Read-Gene had revenue of 3.43M PLN in the quarter ending June 30, 2025, with 15.83% growth. This brings the company's revenue in the last twelve months to 15.14M, up 30.19% year-over-year. In the year 2024, Read-Gene had annual revenue of 13.23M with 30.38% growth.
Revenue (ttm)
15.14M
Revenue Growth
+30.19%
P/S Ratio
4.36
Revenue / Employee
841.06K
Employees
30
Market Cap
66.02M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.23M | 3.08M | 30.38% |
Dec 31, 2023 | 10.15M | 2.91M | 40.14% |
Dec 31, 2022 | 7.24M | 787.35K | 12.20% |
Dec 31, 2021 | 6.45M | 384.57K | 6.34% |
Dec 31, 2020 | 6.07M | -296.62K | -4.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.06B |
NEUCA | 12.82B |
Voxel | 556.98M |
Synektik Spólka Akcyjna | 623.20M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |